Saudi Arabia In-Vitro Fertilization (IVF) Market Forecasts and Opportunities, 2030: Competitive Intelligence Reveals New Frontiers in Medical Tourism and Fertility Solutions
The Saudi Arabia IVF market is poised for growth due to rising awareness of infertility, societal acceptance of various family structures, and technological advancements like ICSI and PGT. Increased demand is fueled by government support, evolving regulations, and fertility preservation services, amidst cultural and ethical challenges.
Saudi Arabian In-Vitro Fertilization (IVF) Market
Dublin, May 29, 2025 (GLOBE NEWSWIRE) -- The "Saudi Arabia In-Vitro Fertilization (IVF) Market, By Region, Competition, Forecast and Opportunities, 2020-2030F" has been added to ResearchAndMarkets.com's offering.
The Saudi Arabia In-Vitro Fertilization (IVF) Market was valued at USD 378.60 Million in 2024 and is expected to reach USD 589.56 Million by 2030, rising at a CAGR of 7.86%
In-Vitro Fertilization (IVF) is a medical procedure designed to help individuals and couples overcome infertility and achieve pregnancy. The term "in vitro" means "in glass," and IVF involves fertilizing an egg with sperm outside the human body in a laboratory setting, typically in a petri dish or a specialized culture medium.
The resulting embryos are then carefully monitored and, in most cases, one or more of the healthiest embryos are selected for transfer into the woman's uterus with the goal of establishing a successful pregnancy. IVF is a complex and highly customizable procedure, and the specific protocols may vary based on individual patient needs and circumstances. The success of IVF can depend on various factors, including the woman's age, the quality of the embryos, and any underlying medical conditions.
A rising awareness of infertility issues and available fertility treatments among both healthcare providers and the public encourages more individuals and couples to seek IVF solutions. In Riyadh, Fertility World offers premier In Vitro Fertilization (IVF) treatment, delivering comprehensive care with the highest success rates. The center provides an affordable IVF package at a cost of USD 3,997.73, making the dream of parenthood a reality for many. Continuous advancements in IVF techniques, equipment, and laboratory procedures improve success rates, making IVF more appealing to patients.
Evolving societal norms and cultural shifts, including greater acceptance of non-traditional family structures, contribute to the increasing demand for IVF treatments. The rise in fertility preservation services for individuals facing medical treatments that may affect their fertility expands the market. Efforts to educate patients about infertility issues, available treatments, and the benefits of IVF can boost demand. The presence of an aging population can contribute to a higher demand for fertility treatments, as advanced maternal age is often associated with infertility. Increasing availability of health insurance coverage for IVF treatments can make these services more accessible and affordable to a wider range of patients.
Government initiatives to promote and subsidize fertility treatments, establish specialized fertility centers, and improve access to IVF services can drive market growth. Well-defined regulations are crucial for developing a scaled and corporatized IVF market, and improvements in the regulatory framework across APAC are driving increased investment. However, there is considerable variability in regulations among countries. Thailand and Malaysia, where gender selection and biological asset transfers are permitted, offer some of the most flexible regulations, though they impose restrictions on foreign ownership of ART clinics (e.g., Thailand limits foreign ownership to 70%). In contrast, the Kingdom of Saudi Arabia (KSA), the UAE, and China enforce more stringent regulatory requirements.
Key Market Drivers
Technological Advancements
Intracytoplasmic Sperm Injection (ICSI) is a breakthrough technology that involves injecting a single sperm directly into an egg. It is particularly beneficial for couples with male infertility issues and has significantly increased IVF success rates. IVF success rates in Saudi Arabia are comparable to those in Dubai, ranging between 40-50%. The country's regulatory framework supports the use of advanced reproductive technologies, and numerous clinics offer comprehensive IVF packages. While Saudi Arabia emphasizes convenience and patient comfort, its offerings may not match the luxury experiences available in Dubai. Additionally, Saudi Arabia adheres to strict ethical guidelines and quality standards, ensuring safe and effective treatments.
Growing Awareness
Growing awareness leads to the establishment of support groups, online forums, and resources for individuals and couples dealing with infertility. These networks provide emotional and informational support, making it easier for people to navigate their fertility journey. Awareness campaigns often emphasize the importance of seeking medical advice early when faced with fertility issues.
National and international awareness initiatives and fertility awareness weeks contribute to educating the public about infertility and available treatments, including IVF. When public figures and celebrities openly share their experiences with infertility and IVF, it can have a profound impact on public awareness and encourage others to seek treatment. As societies evolve and embrace changing family structures, awareness campaigns can help individuals see IVF as a viable option for building their families. This factor will pace up the demand of the Saudi Arabia In-Vitro Fertilization (IVF) Market.
Rising Fertility Preservation
Patients facing medical treatments such as chemotherapy, radiation, or surgeries that can impair fertility often choose to preserve their gametes (eggs or sperm) before undergoing these treatments. After completing their medical treatment, many of these individuals turn to IVF to achieve a pregnancy. Some individuals choose to delay parenthood due to personal or professional reasons, but they wish to ensure their fertility options for the future. Fertility preservation, such as egg freezing, allows them to extend their reproductive lifespan, and they may later use IVF to conceive when they are ready to start a family. Women who are concerned about the natural decline in fertility with age may opt for egg freezing to preserve their younger, healthier eggs. Later, they may use IVF to thaw and fertilize these preserved eggs to achieve pregnancy.
Key Market Challenges
Ethical Concerns and Stigma
Saudi Arabia, as an Islamic nation, follows strict religious principles. Some interpretations of Islamic law raise ethical concerns about IVF, especially issues related to the use of third-party gametes (egg or sperm donation), surrogacy, and pre-implantation genetic testing. Religious leaders' opinions can influence public perception. There can be social stigma associated with infertility and the use of fertility treatments, which may deter individuals and couples from seeking IVF. Privacy is highly valued in Saudi society, and the disclosure of fertility issues can be uncomfortable for many.
Affordability
IVF is a complex and resource-intensive medical procedure. The costs associated with IVF treatments, including medications, laboratory tests, and medical consultations, can be substantial. These high costs can make IVF out of reach for many potential patients. IVF success is not guaranteed in a single cycle, and many patients require multiple cycles to achieve a pregnancy. The need for multiple attempts significantly increases the overall cost of IVF. Fertility medications, such as hormones and gonadotropins used in IVF, can be expensive. Patients often require several medications during their IVF cycle, adding to the financial burden.
Key Market Trends: Medical Tourism
Saudi Arabia has invested heavily in developing state-of-the-art healthcare infrastructure, including cutting-edge IVF facilities and specialized fertility clinics. This infrastructure attracts international patients seeking high-quality IVF treatments. The medical tourism market in Saudi Arabia is expected to reach USD 0.54 billion by 2029. A major factor contributing to this growth is the cost-effectiveness of medical procedures in Saudi Arabia, which are often more affordable than in many patients' home countries, particularly for elective or non-emergency treatments. The presence of highly trained and experienced fertility specialists and medical professionals in Saudi Arabia adds to the appeal for international patients.
Key Attributes:
Report Attribute
Details
No. of Pages
85
Forecast Period
2024 - 2030
Estimated Market Value (USD) in 2024
$378.6 Million
Forecasted Market Value (USD) by 2030
$589.56 Million
Compound Annual Growth Rate
7.8%
Regions Covered
Saudi Arabia
Report Scope
Key Market Players:
Dr. Sulaiman Alhabib Medical Group
HealthPlus Fertility & Women's Health Center
Dr. Samir Abbas Medical Centers
Dr. Khalid Idriss Hospital
KKUH - Assisted Conception Unit
King Faisal Specialist Hospital
Saad Hospital IVF Center
Al Manaa General Hospital IVF Unit
Thuriah Medical Center
Bnoon Medical Center
Saudi Arabia In-Vitro Fertilization (IVF) Market, By Technique:
ICS/IVF
Non-ICSI/Traditional IVF
Saudi Arabia In-Vitro Fertilization (IVF) Market, By Reagent:
Embryo Culture Media
Cryopreservation Media
Sperm Processing Media
Ovum Processing Media
Saudi Arabia In-Vitro Fertilization (IVF) Market, By Instrument:
Imaging Systems
Incubators
Cryo-systems
Sperm Separation Systems
Ovum Aspiration Pumps
Micromanipulator Systems
Others
Saudi Arabia In-Vitro Fertilization (IVF) Market, By Infertility:
Female
Male
Saudi Arabia In-Vitro Fertilization (IVF) Market, By Embryo:
Frozen-Thawed Embryo
Fresh Embryo
Saudi Arabia In-Vitro Fertilization (IVF) Market, By Application:
Fertility Clinics
Hospitals
Others
Saudi Arabia In-Vitro Fertilization (IVF) Market, By End-User:
Locals
Expats
Medical Tourists
Saudi Arabia In-Vitro Fertilization (IVF) Market, By Region:
Eastern
Western
Northern & Central
Southern
For more information about this report visit https://www.researchandmarkets.com/r/g2azaa
About ResearchAndMarkets.comResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
Saudi Arabian In-Vitro Fertilization (IVF) Market
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
21 minutes ago
- Yahoo
Foundation for Sarcoidosis Research Announces 2025 Global Virtual Sarcoidosis Summit – United for Progress: A New Chapter in Sarcoidosis
CHICAGO, June 04, 2025 (GLOBE NEWSWIRE) -- The Foundation for Sarcoidosis Research (FSR), the leading international organization dedicated to finding a cure for sarcoidosis and improving patient support, is proud to announce the 2025 FSR Global Virtual Sarcoidosis Summit, taking place Saturday, June 28, through Sunday, June 29, 2025. This year's theme, "United for Progress: A New Chapter in Sarcoidosis," emphasizes connection, education, and empowerment for individuals impacted by sarcoidosis around the world. Now in its fourth year, the FSR Global Virtual Sarcoidosis Summit is the world's largest online sarcoidosis event, bringing together patients, caregivers, clinicians, and researchers for two days of expert-led sessions, interactive discussion forums, and community-building opportunities. The summit offers critical tools and knowledge to help attendees take control of their health, better understand the disease, and find a global support network. 'The 2025 Summit is more than just an event — it's a powerful opportunity to unite the global sarcoidosis community around shared learning, personal empowerment, and collective progress,' said Mary McGowan, FSR President and CEO. 'With sessions designed for patients, caregivers, and clinicians alike, the summit aims to break down barriers to care and ensure that no one has to face sarcoidosis alone.' Attendees will explore over 20 live and on-demand sessions led by world-renowned sarcoidosis experts, covering critical and rarely discussed topics including: Sarcoidosis 101: From Diagnosis to Management Environmental Triggers in Sarcoidosis Genetics and Familial Connections Intimacy and Sarcoidosis Fatigue, Brain Fog, and Invisible Symptoms What's Sarcoidosis and What's Not? Understanding Organ Involvement, Monitoring, and Shared Decisions Ask the Sarcoidosis Experts Rare Manifestations of Sarcoidosis Nutrition, Lifestyle, and Mental Health Strategies Navigating Insurance and Access to Care FSR is honored to welcome actress and sarcoidosis advocate, Jeryl Prescott Gallien, as the 2025 Summit keynote speaker. Best known for roles in Star Wars, The Walking Dead, Swamp Thing, and All the Queen's Men, Jeryl brings a powerful voice as someone living with cardiac sarcoidosis. Through her advocacy, including work with FSR's 'Ignore No More' campaign, she has helped raise national awareness about the disease and its disproportionate impact on Black women. Her keynote will offer inspiration, insight, and a deeply personal perspective on the power of community in the face of chronic illness. Interactive community forums, video chats, and a virtual exhibit hall featuring more than 20 educational booths will allow participants to connect, ask questions, and access trusted resources. FSR's Global Sarcoidosis Clinic Alliance members will also be present to offer local and specialized care insights. Registration will close on June 14, 2025. Scholarships are available for those in need of financial assistance. All registrants will receive 30-day access to summit session recordings and resources to view post-event. To register, apply for a scholarship, or learn more, visit: Sarcoidosis Sarcoidosis is a rare inflammatory disease that causes the immune system to form granulomas—clusters of inflammatory cells—in one or more organs. Symptoms can vary widely and may include fatigue, shortness of breath, chronic pain, and neurological issues. Sarcoidosis is difficult to diagnose and currently has no known cure. About the Foundation for Sarcoidosis Research (FSR) The Foundation for Sarcoidosis Research (FSR) is the leading international organization dedicated to finding a cure for sarcoidosis and improving patient care through research, education, and support. Since its founding in 2000, FSR has invested over $8 million in sarcoidosis-specific research and built a global community of support. Learn more at Media Contact: Cathi Davis Director of Communications and Marketing 312-341-0500 cathi@ A photo accompanying this announcement is available at
Yahoo
31 minutes ago
- Yahoo
Sutter Health Breaks Ground on $442 Million Neuroscience Complex in San Francisco
State-of-the-art facility at CPMC's Mission Bernal campus will bring together leading-edge neurological care, research and technology under one roof Artist rendering: Sutter Advanced Neuroscience Complex in San Francisco Groundbreaking for Sutter Advanced Neuroscience Complex in San Francisco SAN FRANCISCO, June 04, 2025 (GLOBE NEWSWIRE) -- Sutter Health today broke ground on the new Sutter Advanced Neuroscience Complex at Mission Bernal – a major milestone in expanding access to high-quality neurological and neurosurgical care in Northern California. The five-story, 129,000-square-foot facility will be located at the corner of César Chávez and Valencia streets (3555 César Chavez Street) in San Francisco and is expected to open in 2028. Designed as a regional destination for brain health, the complex will unite care delivery, advanced diagnostics and research in one location. 'Sutter Health has a bold vision for brain health, and that vision includes building a state-of-the-art advanced neuroscience complex in San Francisco,' said Sutter Health President and CEO Warner Thomas. 'CPMC has cared for this community since the 1850s, and we're proud to continue that legacy by investing in a destination for neurological care that will serve patients and families locally and across the region. Our mission drives us to deliver accessible, high-quality care that fuels innovation and expands access so that more people can benefit from the highest standards of neurological health closer to home.' 'San Francisco is leading the nation in providing cutting-edge health care, and this project will bring exceptional neurological care to the heart of our city and better health outcomes for our residents,' said Mayor Daniel Lurie. 'Thank you to Sutter Health for their commitment to our city, to our residents, and to the Mission District. Together, we're building stronger, healthier communities and strengthening San Francisco's comeback.' High-Tech Hub for Brain Health This $442 million investment underscores Sutter Health's long-term commitment to expanding access to specialized, high-acuity care in San Francisco and the broader Bay Area. When complete, the Sutter Advanced Neuroscience Complex at Mission Bernal will bring together approximately 80 physicians and clinicians across range of neurological specialties – including Alzheimer's disease and dementia, ALS, headache, neurosurgery, neurology, epilepsy, neuro-oncology and movement disorders – to deliver seamless, integrated care in one location. The new complex will house a full spectrum of services, including neurology, neurosurgery, imaging, lab, infusion, rehabilitation and an on-site ambulatory surgery center. Patients will also benefit from direct access to leading research and clinical trials, further supporting advancements in diagnosis and treatment. Two of Sutter's nationally recognized programs – the Ray Dolby Brain Health Center and the Forbes Norris MDA/ALS Research and Treatment Center – will relocate to the new complex, enabling greater capacity and deeper collaboration among specialists. The site will also include underground parking to improve convenience for patients and visitors. In a related investment, Sutter plans to add two neurological intervention suites to the adjacent CPMC Mission Bernal campus hospital by 2027. These suites will offer advanced imaging and enable rapid detection and minimally invasive treatment of life-threatening neurological conditions. 'Our goal is to provide coordinated, comprehensive access to integrated care that merges the expertise of neurologists and neurosurgeons,' said Dr. Lewis Leng, a neurosurgeon with Sutter West Bay Medical Group. 'The new Sutter Advanced Neuroscience Complex at Mission Bernal will create more access to care for patients with neurological conditions and provide them the opportunity to take advantage of Sutter's award-winning neuroscience treatment and clinical research.' Christina Oh, president of Sutter's Greater San Francisco Division, added, 'Patients will be able to come to this location and visit their specialist, receive diagnostic lab and imaging, as well as outpatient procedures all in one complex. Having all these services under one roof will create a more convenient, coordinated experience.' The Sutter Advanced Neuroscience Complex is part of Sutter Health's broader strategy to invest nearly $1 billion in healthcare infrastructure across San Francisco over the next five years. This initiative aims to significantly expand access to specialized medical care, such as Sutter's new Otolaryngology-Head and Neck Surgery program, and enhance the overall patient experience. A Vision for Advanced Care and Clinical Training The Mission Bernal Care Complex is part of a larger effort by Sutter Health to address the growing healthcare needs of Northern California, with more than two dozen new facilities currently in development. Beyond expanding access, this complex reflects Sutter's strong commitment to education and workforce development, with plans to train over 1,000 medical residents and fellows by 2030. Sutter CPMC plays a key role in this effort, currently training residents and fellows in nationally accredited Graduate Medical Education programs across a wide range of specialties, including advanced heart failure and transplant cardiology, cardiovascular disease, internal medicine, gastroenterology, hand surgery, hematology-oncology, ophthalmology, pulmonary and critical care medicine, psychiatry and transplant hepatology. CPMC also offers additional training in neurocritical care, among other areas. 'This groundbreaking represents a pivotal moment in advancing Sutter Health's mission to provide high-quality, compassionate and innovative care,' said Ken McNeely, chair of the Sutter Health Board of Directors. 'It reflects our dedication to meeting the evolving healthcare needs of our community while preparing the next generation of physicians and care teams to carry that mission forward.' For more information about the Sutter Advanced Neuroscience Complex at Mission Bernal and Sutter Health's ongoing commitment to healthcare excellence, please visit About Sutter Health Sutter Health is a not-for-profit health care system dedicated to providing comprehensive care throughout California. Committed to community partnerships and innovative, high-quality patient care, Sutter Health is pursuing a bold new plan to reach more people and make excellent health care more connected and accessible. Sutter Health currently serves nearly 3.5 million patients, thanks to a dedicated team of more than 57,000 employees and clinicians and 12,000+ affiliated physicians, with a unified focus on expanding care to serve more patients. Sutter delivers exceptional and affordable care through its hospitals, medical groups, ambulatory surgery centers, urgent care clinics, telehealth, home health, and hospice services. Dedicated to transforming health care, at Sutter Health, getting better never stops. Learn more about how Sutter Health is transforming health care at and Attachments Artist rendering: Sutter Advanced Neuroscience Complex in San Francisco Groundbreaking for Sutter Advanced Neuroscience Complex in San Francisco CONTACT: Ashley Boarman Sutter Health 443-248-4532 boarmaa@ in to access your portfolio
Yahoo
an hour ago
- Yahoo
LGI Homes, Inc. Reports May 2025 Home Closings
THE WOODLANDS, Texas, June 04, 2025 (GLOBE NEWSWIRE) -- LGI Homes, Inc. (NASDAQ: LGIH) today announced it closed 416 homes in May 2025. As of May 31, 2025, the Company had 145 active selling communities. About LGI Homes, Inc. Headquartered in The Woodlands, Texas, LGI Homes, Inc. is a pioneer in the homebuilding industry, successfully applying an innovative and systematic approach to the design, construction and sale of homes across 36 markets in 21 states. As one of America's fastest growing companies, LGI Homes has closed over 75,000 homes since its founding in 2003 and has delivered profitable financial results every year. Nationally recognized for its quality construction and exceptional customer service, LGI Homes was named to Newsweek's list of the World's Most Trustworthy Companies. LGI Homes' commitment to excellence extends to its more than 1,000 employees, earning the Company numerous workplace awards at the local, state, and national level, including the Top Workplaces USA 2025 Award. For more information about LGI Homes and its unique operating model focused on making the dream of homeownership a reality for families across the nation, please visit the Company's website at CONTACT:Joshua D. FattorExecutive Vice President, Investor Relations and Capital Markets(281) 210-2586investorrelations@ in to access your portfolio